Postmenopausal Sexual Disorders. Other sexual disorders
Conditions
Interventions
Intervention 1: Intervention group:intake of Zink Sulfate capsule 110 mg Alhavi Pharmaceutical Company daily for 42 days. Intervention 2: Control group:Intake placebo daily for 42 days.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
49 Years to No maximum
Inclusion criteria
Inclusion criteria: Married women At least one year and a maximum of 5 years since the last menstrual period Minimum literacy 49 years and up People whose FSFI score is <26.5 Those who achieved according ton Larsson questionnaire of sexual dissatisfaction (score of 50 and below), low sexual satisfaction (score of 51-75) People whose fasting plasma zinc is less than 62 micrograms / dL
Exclusion criteria
Exclusion criteria: Having at least one known chronic illness Current experience of mental disorders and depression in the sample of the researcher and his wife Addiction, alcohol abuse and smoking Drugs affecting sexual function Those who use replacement hormones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual Function: A set of sexual responses and reactions including sexual desire, satisfaction, vaginal lubrication, orgasm and pain in sexual intercourse with the spouse, which is determined by the Sexual Function Index Questionnaire with a FSFI score greater than or equal to 26.5 Desirable Sexual Function and FSFI score less than 26.5 is considered sexual dysfunction and people with FSFI score less than 26.5 are included in the study. Timepoint: Day zero and 43. Method of measurement: FSFI questionnaire.;Sexual satisfaction: means the objective feelings of satisfaction, satisfaction, and enjoyment experienced by a spouse when considering all aspects of their marriage. Persons who, according to the Larsson Questionnaire of Sexual dissatisfaction (score 50 and below), low sexual satisfaction (score51-75) they enter the study. Timepoint: Day zero and 43. Method of measurement: Larson questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Testosterone levels. Timepoint: Before the study and day 43. Method of measurement: The radioimmunoassay method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Mazaheri nia
Ahvaz University of Medical Sciences
Outcome results
None listed